3 results
Approved WMOCompleted
The primary objective is:* To determine the overall response rate (ORR) of 4 weekly infusions of obinutuzumab monotherapy (Induction I) in patients with rituximab-refractory follicular lymphoma.The secondary objectives are:* To determine the…
Approved WMOCompleted
To evaluate the performance of MCS in cleansing a poorly prepared colon.
Approved WMOCompleted
This is a feasibility study of the System to assess safety and performance in patients scheduled to undergo esophagectomy.